Skip to main content
Top
Published in: BMC Cancer 1/2012

Open Access 01-12-2012 | Research article

Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare

Authors: Robert I Griffiths, Mark D Danese, Michelle L Gleeson, José M Valderas

Published in: BMC Cancer | Issue 1/2012

Login to get access

Abstract

Background

In breast cancer, diabetes diagnosed prior to cancer (previously diagnosed) is associated with advanced cancer stage and increased mortality. However, in the general population, 40% of diabetes is undiagnosed until glucose testing, and evidence suggests one consequence of increased evaluation and management around breast cancer diagnosis is the increased detection of previously undiagnosed diabetes. Biological factors – for instance, higher insulin levels due to untreated disease - and others underlying the association between previously diagnosed diabetes and breast cancer could differ in those whose diabetes remains undiagnosed until cancer. Our objectives were to identify factors associated with previously undiagnosed diabetes in breast cancer, and to examine associations between previously undiagnosed diabetes and cancer stage, treatment patterns, and mortality.

Methods

Using Surveillance, Epidemiology, and End Results-Medicare, we identified women diagnosed with breast cancer and diabetes between 01/2001 and 12/2005. Diabetes was classified as previously diagnosed if it was identified within Medicare claims between 24 and 4 months before cancer diagnosis, and previously undiagnosed if it was identified from 3 months before to ≤ 3 months after cancer. Patients were followed until 12/2007 or death, whichever came first. Multivariate analyses were performed to examine risk factors for previously undiagnosed diabetes and associations between undiagnosed (compared to previously diagnosed) diabetes, cancer stage, treatment, and mortality.

Results

Of 2,418 patients, 634 (26%) had previously undiagnosed diabetes; the remainder had previously diagnosed diabetes. The mean age was 77.8 years, and 49.4% were diagnosed with in situ or stage I disease. Age > 80 years (40% of the cohort) and limited health system contact (primary care physician and/or preventive services) prior to cancer were associated with higher adjusted odds of previously undiagnosed diabetes. Previously undiagnosed diabetes was associated with higher adjusted odds of advanced stage (III/IV) cancer (Odds Ratio = 1.37: 95% Confidence Interval (CI) 1.05 – 1.80; P = 0.02), and a higher adjusted mortality rate due to causes other than cancer (Hazard Ratio = 1.29; 95% CI 1.02 – 1.63; P = 0.03).

Conclusions

In breast cancer, previously undiagnosed diabetes is associated with advanced stage cancer and increased mortality. Identifying biological factors would require further investigation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002/ijc.22717.CrossRefPubMed Larsson SC, Mantzoros CS, Wolk A: Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007, 121: 856-862. 10.1002/ijc.22717.CrossRefPubMed
2.
go back to reference Peairs KS, Barone BB, Snyder CF, Yeh H-C, Stein KB, Derr RL, Brancati FL, Wolff AC: Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011, 29 (1): 40-46. 10.1200/JCO.2009.27.3011.CrossRefPubMed Peairs KS, Barone BB, Snyder CF, Yeh H-C, Stein KB, Derr RL, Brancati FL, Wolff AC: Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011, 29 (1): 40-46. 10.1200/JCO.2009.27.3011.CrossRefPubMed
3.
go back to reference Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K: The impact of type 2 diabetes mellitus on cancer-specific survival. Cancer. 2012, 118: 1353-1361. 10.1002/cncr.26420.CrossRefPubMed Liu X, Ji J, Sundquist K, Sundquist J, Hemminki K: The impact of type 2 diabetes mellitus on cancer-specific survival. Cancer. 2012, 118: 1353-1361. 10.1002/cncr.26420.CrossRefPubMed
4.
go back to reference Schrauder MG, Fasching PA, Habërle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, et al: Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol. 2011, 137: 975-983. 10.1007/s00432-010-0960-2.CrossRefPubMed Schrauder MG, Fasching PA, Habërle L, Lux MP, Rauh C, Hein A, Bayer CM, Heusinger K, Hartmann A, Strehl JD, et al: Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol. 2011, 137: 975-983. 10.1007/s00432-010-0960-2.CrossRefPubMed
5.
go back to reference Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP: Clinically defined type 2 diabetes mellitus and prognosis in early stage breast cancer. J Clin Oncol. 2011, 29 (1): 54-60. 10.1200/JCO.2010.29.3183.CrossRefPubMed Erickson K, Patterson RE, Flatt SW, Natarajan L, Parker BA, Heath DD, Laughlin GA, Saquib N, Rock CL, Pierce JP: Clinically defined type 2 diabetes mellitus and prognosis in early stage breast cancer. J Clin Oncol. 2011, 29 (1): 54-60. 10.1200/JCO.2010.29.3183.CrossRefPubMed
6.
go back to reference Srokowski TP, Fang S, Hortobagyi GN, Giordano SH: Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009, 27 (13): 2170-2176. 10.1200/JCO.2008.17.5935.CrossRefPubMedPubMedCentral Srokowski TP, Fang S, Hortobagyi GN, Giordano SH: Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol. 2009, 27 (13): 2170-2176. 10.1200/JCO.2008.17.5935.CrossRefPubMedPubMedCentral
7.
go back to reference Van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR: Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population-based analysis. Int J Cancer. 2007, 120: 1986-1992. 10.1002/ijc.22532.CrossRefPubMed Van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR: Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population-based analysis. Int J Cancer. 2007, 120: 1986-1992. 10.1002/ijc.22532.CrossRefPubMed
8.
go back to reference Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001, 285 (7): 885-892. 10.1001/jama.285.7.885.CrossRefPubMed Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW: Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA. 2001, 285 (7): 885-892. 10.1001/jama.285.7.885.CrossRefPubMed
9.
go back to reference Zhou XH, Qiao Q, Zethilius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CDA, Heine RJ, Jousilahti P, Ruotolo G, for the DECODE Study Group, et al: Diabetes, prediabetes and cancer mortality. Diabetologia. 2010, 53: 1867-1876. 10.1007/s00125-010-1796-7.CrossRefPubMed Zhou XH, Qiao Q, Zethilius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CDA, Heine RJ, Jousilahti P, Ruotolo G, for the DECODE Study Group, et al: Diabetes, prediabetes and cancer mortality. Diabetologia. 2010, 53: 1867-1876. 10.1007/s00125-010-1796-7.CrossRefPubMed
10.
go back to reference Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM: Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care. 2012, Published online June 14, 2012 Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM: Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care. 2012, Published online June 14, 2012
11.
go back to reference Patnaik JL, Byers T, DiGuiseppi C, Dabela D, Denberg TD: Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011, 13: R64-10.1186/bcr2901.CrossRefPubMedPubMedCentral Patnaik JL, Byers T, DiGuiseppi C, Dabela D, Denberg TD: Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res. 2011, 13: R64-10.1186/bcr2901.CrossRefPubMedPubMedCentral
12.
go back to reference Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE: The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat. 2008, 109: 389-395. 10.1007/s10549-007-9654-0.CrossRefPubMed Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE: The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat. 2008, 109: 389-395. 10.1007/s10549-007-9654-0.CrossRefPubMed
13.
go back to reference Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D: Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005, 294: 1765-1772. 10.1001/jama.294.14.1765.CrossRefPubMed Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D: Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005, 294: 1765-1772. 10.1001/jama.294.14.1765.CrossRefPubMed
14.
go back to reference Du W, Simon MS: Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005, 91: 243-248. 10.1007/s10549-005-0324-9.CrossRefPubMed Du W, Simon MS: Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat. 2005, 91: 243-248. 10.1007/s10549-005-0324-9.CrossRefPubMed
15.
go back to reference Fleming ST, Rastogi A, Dmitrienko A, Johnson KD: A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999, 37 (6): 601-614. 10.1097/00005650-199906000-00009.CrossRefPubMed Fleming ST, Rastogi A, Dmitrienko A, Johnson KD: A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999, 37 (6): 601-614. 10.1097/00005650-199906000-00009.CrossRefPubMed
16.
go back to reference Wolf I, Catane R, Karasik A, Kaufman B: Diabetes mellitus and breast cancer. Lancet Oncol. 2005, 6: 103-111. 10.1016/S1470-2045(05)01736-5.CrossRefPubMed Wolf I, Catane R, Karasik A, Kaufman B: Diabetes mellitus and breast cancer. Lancet Oncol. 2005, 6: 103-111. 10.1016/S1470-2045(05)01736-5.CrossRefPubMed
17.
go back to reference Giovannuci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D: Diabetes and cancer: a consensus report. Diabetes Care. 2010, 33 (7): 1674-1685. 10.2337/dc10-0666.CrossRef Giovannuci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D: Diabetes and cancer: a consensus report. Diabetes Care. 2010, 33 (7): 1674-1685. 10.2337/dc10-0666.CrossRef
18.
go back to reference DeCensi A, Gennari A: Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol. 2011, 29 (1): 7-10. 10.1200/JCO.2010.32.3022.CrossRefPubMed DeCensi A, Gennari A: Insulin breast cancer connection: confirmatory data set the stage for better care. J Clin Oncol. 2011, 29 (1): 7-10. 10.1200/JCO.2010.32.3022.CrossRefPubMed
19.
go back to reference Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS: Screening mammogram utilization in women with diabetes. Diabetes Care. 2001, 24 (12): 2049-2053. 10.2337/diacare.24.12.2049.CrossRefPubMed Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS: Screening mammogram utilization in women with diabetes. Diabetes Care. 2001, 24 (12): 2049-2053. 10.2337/diacare.24.12.2049.CrossRefPubMed
20.
go back to reference McBean AM, Yu X: The underuse of screening services among elderly women with diabetes. Diabetes Care. 2007, 30 (6): 1466-1472. 10.2337/dc06-2233.CrossRefPubMed McBean AM, Yu X: The underuse of screening services among elderly women with diabetes. Diabetes Care. 2007, 30 (6): 1466-1472. 10.2337/dc06-2233.CrossRefPubMed
21.
go back to reference Keating NL, Landrum MB, Ayanian JZ, Winder EP, Guadagnoli E: The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med. 2004, 20: 38-44.CrossRef Keating NL, Landrum MB, Ayanian JZ, Winder EP, Guadagnoli E: The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med. 2004, 20: 38-44.CrossRef
22.
go back to reference Gornick ME, Eggers PW, Riley GF: Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. HSR: Health Services Res. 2004, 39 (5): 1403-1427. 10.1111/j.1475-6773.2004.00296.x. Gornick ME, Eggers PW, Riley GF: Associations of race, education, and patterns of preventive service use with stage of cancer at time of diagnosis. HSR: Health Services Res. 2004, 39 (5): 1403-1427. 10.1111/j.1475-6773.2004.00296.x.
23.
go back to reference Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K: Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005, 43: 132-140. 10.1097/00005650-200502000-00006.CrossRefPubMed Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K: Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care. 2005, 43: 132-140. 10.1097/00005650-200502000-00006.CrossRefPubMed
24.
go back to reference Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008, 300 (23): 2754-2764. 10.1001/jama.2008.824.CrossRefPubMedPubMedCentral Barone BB, Yeh H-C, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL: Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008, 300 (23): 2754-2764. 10.1001/jama.2008.824.CrossRefPubMedPubMedCentral
25.
go back to reference Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Medical Quality. 1999, 14 (6): 270-277. 10.1177/106286069901400607.CrossRef Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Medical Quality. 1999, 14 (6): 270-277. 10.1177/106286069901400607.CrossRef
26.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000, 53: 1258-1267. 10.1016/S0895-4356(00)00256-0.CrossRefPubMed Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000, 53: 1258-1267. 10.1016/S0895-4356(00)00256-0.CrossRefPubMed
27.
go back to reference Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, et al: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009, 32 (2): 287-294.CrossRefPubMedPubMedCentral Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, Williams DE, Gregg EW, Bainbridge KE, Saydah SH, et al: Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009, 32 (2): 287-294.CrossRefPubMedPubMedCentral
28.
go back to reference Danese MD, O’Malley C, Lindquist K, Gleeson M, Griffiths RI: An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol. 2011, Epub ahead of print Danese MD, O’Malley C, Lindquist K, Gleeson M, Griffiths RI: An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer. Ann Oncol. 2011, Epub ahead of print
29.
go back to reference Executive summary: standards of medical care in diabetes – 2011. Diabetes Care. 2011, 34 (suppl. 1): S4-S10. Executive summary: standards of medical care in diabetes – 2011. Diabetes Care. 2011, 34 (suppl. 1): S4-S10.
30.
go back to reference Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009, 8 (6): 909-915. 10.4161/cc.8.6.7933.CrossRefPubMed Alimova IN, Liu B, Fan Z, Edgerton SM, Dillon T, Lind SE, Thor AD: Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro. Cell Cycle. 2009, 8 (6): 909-915. 10.4161/cc.8.6.7933.CrossRefPubMed
31.
go back to reference Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung M-C, Hortobagyi GN, Gonzalez-Angulo AM: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009, 27 (20): 3297-3302. 10.1200/JCO.2009.19.6410.CrossRefPubMedPubMedCentral Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, Hsu L, Hung M-C, Hortobagyi GN, Gonzalez-Angulo AM: Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol. 2009, 27 (20): 3297-3302. 10.1200/JCO.2009.19.6410.CrossRefPubMedPubMedCentral
32.
go back to reference Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol. 2003, 157 (12): 1092-1100. 10.1093/aje/kwg100.CrossRefPubMed Saydah SH, Loria CM, Eberhardt MS, Brancati FL: Abnormal glucose tolerance and the risk of cancer death in the United States. Am J Epidemiol. 2003, 157 (12): 1092-1100. 10.1093/aje/kwg100.CrossRefPubMed
33.
go back to reference Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002, 40: IV-18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF: Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002, 40: IV-18.
36.
go back to reference SEER program code manual. Edited by: Fritz A, Ries L. 1998, Bethesda: Cancer Statistics Branch, Surveillance Program, Div of Cancer Control and Pop Sciences, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Dept of Health and Human Services, 3 SEER program code manual. Edited by: Fritz A, Ries L. 1998, Bethesda: Cancer Statistics Branch, Surveillance Program, Div of Cancer Control and Pop Sciences, National Cancer Institute, National Institutes of Health, Public Health Service, U.S. Dept of Health and Human Services, 3
37.
go back to reference Klabunde CN, Legler JM, Warren JL, Baldwin L-M, Schrag D: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007, 17: 584-590. 10.1016/j.annepidem.2007.03.011.CrossRefPubMed Klabunde CN, Legler JM, Warren JL, Baldwin L-M, Schrag D: A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol. 2007, 17: 584-590. 10.1016/j.annepidem.2007.03.011.CrossRefPubMed
40.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40 (5): 373-383. 10.1016/0021-9681(87)90171-8.CrossRefPubMed
41.
go back to reference Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45 (6): 613-619. 10.1016/0895-4356(92)90133-8.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992, 45 (6): 613-619. 10.1016/0895-4356(92)90133-8.CrossRefPubMed
42.
go back to reference Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K: A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol. 1994, 47: 249-260. 10.1016/0895-4356(94)90006-X.CrossRefPubMed Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K: A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol. 1994, 47: 249-260. 10.1016/0895-4356(94)90006-X.CrossRefPubMed
43.
go back to reference Davidoff AJ, Tang M, Seal B, Edelman MJ: Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010, 28 (13): 2191-2197. 10.1200/JCO.2009.25.4052.CrossRefPubMed Davidoff AJ, Tang M, Seal B, Edelman MJ: Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol. 2010, 28 (13): 2191-2197. 10.1200/JCO.2009.25.4052.CrossRefPubMed
44.
go back to reference Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002, 40 (8 Suppl): IV-55-IV-61. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002, 40 (8 Suppl): IV-55-IV-61.
46.
go back to reference ResDAC. Research Data Assistance Center: CMS 301: Using SEER/Medicare data for research. 2008, MN: ResDAC, Minneapolis ResDAC. Research Data Assistance Center: CMS 301: Using SEER/Medicare data for research. 2008, MN: ResDAC, Minneapolis
47.
go back to reference Glymour MM, Greenland S: Causal diagrams. Modern epidemiology. Edited by: Rothman KJ, Greenland S, Lash TL. 2008, Philadelphia: Lippincott Williams and Wilkins, 183-209. Third Edition Glymour MM, Greenland S: Causal diagrams. Modern epidemiology. Edited by: Rothman KJ, Greenland S, Lash TL. 2008, Philadelphia: Lippincott Williams and Wilkins, 183-209. Third Edition
48.
go back to reference Hernán MA, Hernández-Díaz S, Robins JM: A structural approach to selection bias. Epidemiology. 2004, 15 (5): 615-625. 10.1097/01.ede.0000135174.63482.43.CrossRefPubMed Hernán MA, Hernández-Díaz S, Robins JM: A structural approach to selection bias. Epidemiology. 2004, 15 (5): 615-625. 10.1097/01.ede.0000135174.63482.43.CrossRefPubMed
49.
go back to reference Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, Poole C: llustrating bias due to conditioning on a collider. Int J Epidemiol. 2010, 39: 417-420. 10.1093/ije/dyp334.CrossRefPubMed Cole SR, Platt RW, Schisterman EF, Chu H, Westreich D, Richardson D, Poole C: llustrating bias due to conditioning on a collider. Int J Epidemiol. 2010, 39: 417-420. 10.1093/ije/dyp334.CrossRefPubMed
50.
go back to reference Ashkenazy R, Abrahamson MJ: Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006, 21: 386-392.CrossRefPubMedPubMedCentral Ashkenazy R, Abrahamson MJ: Medicare coverage for patients with diabetes. A national plan with individual consequences. J Gen Intern Med. 2006, 21: 386-392.CrossRefPubMedPubMedCentral
Metadata
Title
Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare
Authors
Robert I Griffiths
Mark D Danese
Michelle L Gleeson
José M Valderas
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2012
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-12-613

Other articles of this Issue 1/2012

BMC Cancer 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine